Cystic Fibrosis Market
                     Title : Cystic Fibrosis Market to Reach USD 31.88 Billion by 2027
Cystic Fibrosis Market to Exhibit a CAGR of 24.4% by 2027; Increasing Awareness regarding  
CF to Lighten Sales Prospects
Description : Cystic Fibrosis Market to Inflate Strongly; Introduction of Ivacaftor to Aid  
Patients with CF, states Fortune Business Insights™
Content :
The global cystic fibrosis market size is predicted to reach USD 31.88 billion by 2027,  
exhibiting a CAGR of 24.4% during the forecast period. The growing cases of respiratory and  
gastrointestinal infection among people can be a critical factor in spurring the demand of  
the market during the forecast period, states Fortune Business Insights in a report, titled  
“Cystic Fibrosis Market Size, Share &Covid-19 Impact Analysis, By Drug Class (Cystic  
Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic,  
Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and  
Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies,  
and Hospital Pharmacies), and Regional Forecast, 2020-2027” the market size stood at USD
5.12 billion in 2019.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this  
health crisis has brought an unprecedented impact on businesses across industries.
However, this too shall pass. Rising support from governments and several companies can  
help in the fight against this highly contagious disease. There are some industries that are  
struggling and some are thriving. Overall, almost every sector is anticipated to be impacted  
by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19  
pandemics. Based on our experience and expertise, we will offer you an impact analysis of  
corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/cystic-fibrosis-market-  
102958
Market Driver:
Rising Adoption of Advanced Treatment Procedures to Augment Growth
The rising concentration towards early diagnosis will have a positive impact on the market  
during the forecast period. The rising cases of genetic disorders have led to the expansion of  
the market. According to the Cystic Fibrosis Patient Registry, it is estimated that more than  
30,000 people are affected by Cystic Fibrosis conditions in the U.S. and it is estimated that  
about 70,000 people are suffering from it across the globe. The growing complications in the  
lungs and pancreas consequently indicate cystic fibrosis, which in turn, will augur well for  the 
market. Moreover, the development of innovative and advanced therapeutics for the  
treatment of fibrosis will have a tremendous impact on the market in the forthcoming years.  
For instance, the introduction of Ivacaftor / Lumacaftor, a potentiator used in the treatment  
for people with CF. In addition, the ongoing pipeline candidates in R&D by leading players  
will further amplify the growth prospects of the market during the forecast period.
Regional Analysis:
High Healthcare Expenditure to Boost Market in North America
The market in North America generated a revenue of USD 3.89 billion in 2019 and is  
expected to rise rapidly during the forecast period owing to the growing prevalence of CF in  
the region. The increasing R&D investment by major industry players will contribute  
positively to the growth of the market. The rising healthcare expenditure along with  
developed medical facilities will foster growth in the region. The inclination towards  
advanced drugs by patients for better outcomes will further improve the scope of the  market 
in North America. Asia Pacific is predicted to account for the lion’s share during the  forecast 
period owing to the rising geriatric patients. Improving healthcare facilities will  enable the 
expansion of the market in Asia Pacific. The rising awareness regarding the  treatment of CF 
will have a positive effect on the market. The Middle East& Africa and Latin  America are 
predicted to witness a steady growth rate owing to the unmet patient needs.  The lack of 
awareness about diseases will further limit growth in the regions.
More Trending Topics from Fortune Business Insights:
Vitiligo Treatment Market Size, Share, Growth, Sales and Drivers Analysis Research Report
2026Vitiligo Treatment Market to Reach US$ 1,944.5 Mn by 2026; Ever Rising Demand for  
Advanced Treatment Options to Propel Market, says Fortune Business Insights